20856 Federal Register / Vol. 72, No. 80 / Thursday, April 26, 2007 / Notices 

and Child Health Coordinator, Maternal 

and Child Health Program, Indian 

Health Service, 801 Thompson Avenue, 

Suite 300, Rm 313, Rockville, Maryland 

20852, voice: 301–443–5070, fax: 301–

594–6213 or judith.thierry@ihs.gov. 

For general information regarding this 

announcement: Ms. Orie Platero, IHS 

Headquarters, Office of Clinical and 

Preventive Services, 801 Thompson 

Avenue, Room 326, Rockville, MD 

20852, (301) 443–2522 or 

orie.platero@ihs.gov. 

3. For specific grant-related and 

business management information: 

Martha Redhouse, Grants Management 

Specialist, 801 Thompson Avenue, TMP 

360, Rockville, MD 20852, 301–443–

5204 or Martha.redhouse@ihs.gov. 

VIII. Other Information 

The IHS is focusing efforts on three 

health initiatives that linked together, 

have the potential to achieve positive 

improvements in the health of American 

Indian and Alaska Native (AI/AN) 

people. These three initiatives are 

Health Promotion/Disease Prevention, 

Management of Chronic Disease, and 

Behavioral Health. Further information 

is available at the Health Initiatives Web 

site: http://www.ihs.gov/nonMedical/ 

Programs/DirInitiatives/index.cfm. 

This agreement supports the 

Department of Health and Human 

Services’ objective in FY 2006 to 

transform the health care system as well 

as the FY 2007 objective to emphasize 

prevention and healthy living as well as 

to accelerate personalized health care. 

Dated: April 19, 2007. 

Robert G. McSwain, 

Deputy Director, Indian Health Service. 

[FR Doc. 07–2051 Filed 4–25–07; 8:45 am] 

BILLING CODE 4165–16–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: The inventions listed below 

are owned by an agency of the U.S. 

Government and are available for 

licensing in the U.S. in accordance with 

35 U.S.C. 207 to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. 

ADDRESSES: Licensing information and 

copies of the U.S. patent applications 

listed below may be obtained by writing 

to the indicated licensing contact at the 

Office of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, 

Maryland 20852–3804; telephone: 301/ 

496–7057; fax: 301/402–0220. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent applications. 

Apparatus for Brachytherapy 

Description of Technology: Available 

for licensing and commercial 

development is a device for delivering 

targeted radiation brachytherapy to a 

portion of tissue in the cavity of a 

patient. The device includes an 

applicator with a balloon where in a 

deflated state is inserted into the body 

cavity and in an inflated state enlarges 

to fill the body cavity. The balloon 

moves from the deflated state into the 

inflated state upon introduction of 

pressurized fluid to the interior of the 

balloon. The apparatus also includes a 

catheter extending over at least a 

portion of the balloon for delivering 

treatment to the adjacent cavity (e.g., 

radiation or heat). A tracking device 

(e.g., a camera) is included in the 

apparatus for helping track the 

positioning of the balloon within the 

body cavity prior to inflation. The 

apparatus can be alternatively 

configured with a second balloon 

containing a therapeutic agent which is 

inflated after positioning and expansion 

with a first balloon first. 

Applications: Brachytherapy; 

Radiation dosing; Cancer therapy. 

Development Status: Early-stage; Preclinical data available; Prototype. 

Inventor: Anurag K. Singh (NCI). 

Patent Status: U.S. Provisional 

Application No. 60/811,762 filed 08 Jun 

2006 (HHS Reference No. E–314–2005/ 

0–US–01). 

Licensing Status: Available for 

licensing non-exclusively or exclusively 

to qualified applicants that satisfy the 

criteria set forth in 37 CFR 404.7. 

Licensing Contact: Michael A. 

Shmilovich, Esq.; 301/435–5019; 

shmilovm@mail.nih.gov. 

Dated: April 18, 2007. 

Steven M. Ferguson, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. E7–7927 Filed 4–25–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: The inventions listed below 

are owned by an agency of the U.S. 

Government and are available for 

licensing in the U.S. in accordance with 

35 U.S.C. 207 to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. 

ADDRESSES: Licensing information and 

copies of the U.S. patent applications 

listed below may be obtained by writing 

to the indicated licensing contact at the 

Office of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, 

Maryland 20852–3804; telephone: 301/ 

496–7057; fax: 301/402–0220. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent applications. 

Biotinylated Alkylating Acridine for 

Pull-downs of Viral Pre-integration 

Complexes (PIC) or Other Cytosol 

Localized DNAs 

Description of Technology: The 

invention describes a DNA-binding 

molecule that allows recovery of viral 

DNA and associated proteins. An 

acridine orange based molecule was 

modified and the resulting alkylating 

acridine molecule intercalates with viral 

pre-integration complexes (PIC) or other 

DNAs localized in cytosol. Because the 

molecule is also biotinylated, 

streptavidin beads can be used to purify 

the molecule and the bound DNA and 

associated protein can subsequently be 

eluted and analyzed. The invention 

provides a useful tool to facilitate the 

studies for viral PIC and other cytosol 

DNAs. 

Applications: Research Tool. 

Development Status: In vitro data 

available. 

Inventors: Gunnar Thor Gunnarsson 

and Rafal Wierzchoslawski (NCI). 

Patent Status: HHS Reference No. E–

131–2007/0—Research Tool. 

Licensing Status: Available for nonexclusive licensing as biological 

material and research tool. 

Licensing Contact: Sally Hu, Ph.D.; 

301/435–5606; HuS@mail.nih.gov. 


rwilkins on PROD1PC63 with NOTICES